Subscribe To
HQL / HQL: Buy For The Yield, If You Can Stomach The Depreciation
HQL News
By Seeking Alpha
September 27, 2023
HQL: Hold Your Investments In This Healthcare CEF For Strong, Steady Yield
Tekla Life Sciences Investors invests primarily in biotechnology stocks, and 10-12 large-cap biotech stocks (50% of total holdings) sets the trend and more_horizontal
By Seeking Alpha
June 29, 2023
By Seeking Alpha
March 8, 2023
HQL: Boom-Bust Returns May Not Be Suitable For High Distribution Yield
HQL focuses on the life sciences industry with a 74% allocation to biotechnology stocks. It pays a 2% quarterly managed distribution. more_horizontal
By Seeking Alpha
December 8, 2022
Equity CEFs: What's Going On With Tekla's HQH And HQL?
The iShares Biotechnology ETF (IBB) is down -12.9% year-to-date but the Tekla biotech equity CEFs are down even more despite NAVs that are holding up more_horizontal
By Seeking Alpha
April 27, 2022
HQL: Buy For The Yield, If You Can Stomach The Depreciation
HQL pays regular quarterly dividends with a close to double-digit yield, and despite poor price growth over medium and long run, HQL's total return is more_horizontal
By Seeking Alpha
February 11, 2022
Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend
HQL pays quarterly dividends. Even during the pandemic, its performance has been better than its peers. Current prices look attractive. more_horizontal
By Seeking Alpha
February 11, 2022
Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend
HQL pays quarterly dividends. Even during the pandemic, its performance has been better than its peers. Current prices look attractive. more_horizontal
By Seeking Alpha
February 11, 2022
Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend
HQL pays quarterly dividends. Even during the pandemic, its performance has been better than its peers. Current prices look attractive. more_horizontal